Results 81 to 90 of about 15,812 (182)

Real-world use of thrombopoietic agents in treatment-naïve children with severe aplastic anemia: a multicenter retrospective study. [PDF]

Sci Rep
Chazli YE, Abdallah G, Zakaria M, Darwish A, Khalifa G, Hassan T, Elhawary E, Elbahy S, Salama M, Alrawas A, Wali Y, Zeid M.   +11 more
europepmc   +1 more source

Personalized Management of Cytopenias in Chronic Liver Disease: From Pathophysiology to Treatment Strategies. [PDF]

JGH Open
Wang X, Fu S, Zhu X, Zhao Y.
europepmc   +1 more source

Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case Report. [PDF]

Clin Case Rep
Innao V, Barbagallo APM, Bianco O, Leotta V, Consoli U.   +4 more
europepmc   +1 more source

Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 study. [PDF]

Br J Haematol
Piatek C, Oladapo A, Kolodny S, Vredenburg M, Lucht S, Bland E, Pathak P, Feinberg B, Maitland H.   +8 more
europepmc   +1 more source

Unintended First-Trimester Exposure to Two Distinct Thrombopoietin Receptor Agonists in Consecutive Pregnancies Without Maternal or Fetal Harm [PDF]

Turk J Haematol
Köseoğlu FD, Kum A.
europepmc   +1 more source

Thrombopoietin. [PDF]

BMJ, 1970
openaire   +2 more sources

Neonatal-Onset Refractory Thrombocytopenia and Anemia Associated With a Homozygous In-Frame NFE2 Duplication. [PDF]

Am J Case Rep
Uddin MS, Albehair M, Alshammari FNM, Esmail A, Shafeen K, Bin Hassan A, Bawazier H.   +6 more
europepmc   +1 more source

MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies. [PDF]

Front Med (Lausanne)
Wang Y, Liu C, Hu Y, Sun X, Zhang W, Zhu W.   +5 more
europepmc   +1 more source

Emerging therapeutic advances for immune thrombocytopenia: highlights from selected early‑phase and pivotal trials at the 2025 ASH annual meeting. [PDF]

Exp Hematol Oncol
Cao L, Wang Z, Xiang Q.
europepmc   +1 more source

Mechanistic insights into voriconazole-exacerbated selpercatinib-induced thrombocytopenia: a pharmacokinetic interaction case report. [PDF]

Front Oncol
Tang H, Zhou Z, Zhang Y, Chen W, Meng J, Li G.   +5 more
europepmc   +1 more source